Literature DB >> 3201921

Observations on demyelinating lesions induced by Theiler's virus in CBA mice.

W F Blakemore1, C J Welsh, P Tonks, A A Nash.   

Abstract

We examined demyelinating lesions in the spinal cord of CBA mice infected with the BeAn strain of Theiler's virus to see if it was possible to document the sequence of changes which result in demyelination. It was found that the lesions which develop in the late stages of the disease were progressive. Therefore, by examining the different zones of a single lesion, it was possible to follow a sequence of changes which lead to demyelination. There was a clear progression from normal myelin, to vacuolated myelin, to myelin phagocytosis, to demyelinated axons, to remyelinated axons. Virus was detected in degenerating oligodendrocytes in the area showing myelin vacuolation by both electron microscopy and immunocytochemistry, a finding which indicated that virus infection precedes demyelination. The area of normal myelin which surrounded the zone of vacuolated myelin was infiltrated by lymphocytes, indicating that lymphocytic infiltration preceded viral replication and oligodendrocyte degeneration. Our observations indicate that cells of the immune system may play a role in the initiation of virus replication which appears to be a prerequisite for demyelination.

Entities:  

Mesh:

Year:  1988        PMID: 3201921     DOI: 10.1007/bf00689596

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  14 in total

1.  The role of the immune response in TMEV infection and the development of late onset demyelination.

Authors:  H C Rauch; I N Montgomery
Journal:  J Immunol       Date:  1986-03-15       Impact factor: 5.422

2.  Theiler's virus in brain cell cultures: lysis of neurons and oligodendrocytes and persistence in astrocytes and macrophages.

Authors:  M C Graves; L Bologa; L Siegel; H Londe
Journal:  J Neurosci Res       Date:  1986       Impact factor: 4.164

3.  Mechanism of Theiler's virus-induced demyelination in nude mice.

Authors:  A Rosenthal; R S Fujinami; P W Lampert
Journal:  Lab Invest       Date:  1986-05       Impact factor: 5.662

4.  Experimental autoimmune encephalomyelitis in mice: genetic control of susceptibility.

Authors:  C C Bernard
Journal:  J Immunogenet       Date:  1976-08

5.  Theiler's virus-induced demyelination: prevention by immunosuppression.

Authors:  H L Lipton; M C Dal Canto
Journal:  Science       Date:  1976-04-02       Impact factor: 47.728

6.  Effects of regional spinal X-irradiation on demyelinating disease caused by Theiler's virus, mouse hepatitis virus or experimental allergic encephalomyelitis.

Authors:  S Love; C A Wiley; R S Fujinami; P W Lampert
Journal:  J Neuroimmunol       Date:  1987-02       Impact factor: 3.478

7.  Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs.

Authors:  R J Clatch; H L Lipton; S D Miller
Journal:  J Immunol       Date:  1986-02-01       Impact factor: 5.422

8.  Demyelinating lesions due to Theiler's virus are associated with ongoing central nervous system infection.

Authors:  M Chamorro; C Aubert; M Brahic
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

9.  Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis.

Authors:  M Rodriguez; J L Leibowitz; P W Lampert
Journal:  Ann Neurol       Date:  1983-04       Impact factor: 10.422

10.  Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region.

Authors:  M Rodriguez; J Leibowitz; C S David
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

View more
  26 in total

1.  Age changes in myelinated nerve fibers of the cingulate bundle and corpus callosum in the rhesus monkey.

Authors:  Michael P Bowley; Howard Cabral; Douglas L Rosene; Alan Peters
Journal:  J Comp Neurol       Date:  2010-08-01       Impact factor: 3.215

2.  Virus persistence in an animal model of multiple sclerosis requires virion attachment to sialic acid coreceptors.

Authors:  A S Manoj Kumar; Honey V Reddi; Aisha Y Kung; Mauro Dal Canto; Howard L Lipton
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

3.  The antiapoptotic protein Mcl-1 controls the type of cell death in Theiler's virus-infected BHK-21 cells.

Authors:  Sevim Yildiz Arslan; Kyung-No Son; Howard L Lipton
Journal:  J Virol       Date:  2011-11-30       Impact factor: 5.103

4.  The relationship between viral RNA, myelin-specific mRNAs, and demyelination in central nervous system disease during Theiler's virus infection.

Authors:  M Yamada; A Zurbriggen; R S Fujinami
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

5.  High numbers of viral RNA copies in the central nervous system of mice during persistent infection with Theiler's virus.

Authors:  M Trottier; P Kallio; W Wang; H L Lipton
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

6.  Major histocompatibility complex-conferred resistance to Theiler's virus-induced demyelinating disease is inherited as a dominant trait in B10 congenic mice.

Authors:  A K Patick; L R Pease; C S David; M Rodriguez
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

7.  Theiler's virus replication in brain macrophages cultured in vitro.

Authors:  M Levy; C Aubert; M Brahic
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

8.  Lymphocyte recognition elements on the VP1 protein of Theiler's virus.

Authors:  E J Usherwood; I C Johnston; L J Lovelidge; P Tonks; A A Nash
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

9.  Central neuroinvasion and demyelination by inflammatory macrophages after peripheral virus infection is controlled by SHP-1.

Authors:  George P Christophi; Paul T Massa
Journal:  Viral Immunol       Date:  2009-12       Impact factor: 2.257

10.  Modulation of macrophage infiltration and inflammatory activity by the phosphatase SHP-1 in virus-induced demyelinating disease.

Authors:  George P Christophi; Chad A Hudson; Michael Panos; Ross C Gruber; Paul T Massa
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.